Biocryst Pharmaceuticals (BCRX) Q4 2024 Earnings

4NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.31
-0.23
-0.14
-0.06

Details

Expected EPS
-0.068
Actual EPS
-0.07
Surprise EPS
-0
Surprise Percent
+2.94%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.07 per share for Q4 2024.

0 Comments

Share your thoughts